Literature DB >> 25147376

Solitary bone plasmacytomas need to flow.

Meletios A Dimopoulos1, Evangelos Terpos1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25147376      PMCID： PMC4141506          DOI： 10.1182/blood-2014-06-579706

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Immunoglobulin free light chains and solitary plasmacytoma of bone.

Authors:  David Dingli; Robert A Kyle; S Vincent Rajkumar; Grzegorz S Nowakowski; Dirk R Larson; John P Bida; Morie A Gertz; Terry M Therneau; L Joseph Melton; Angela Dispenzieri; Jerry A Katzmann
Journal:  Blood       Date:  2006-06-01       Impact factor: 22.113

2.  Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.

Authors:  Eirini Katodritou; Evangelos Terpos; Argiris S Symeonidis; Anastasia Pouli; Charikleia Kelaidi; Marie-Christine Kyrtsonis; Maria Kotsopoulou; Sosana Delimpasi; Anna Christoforidou; Nikolaos Giannakoulas; Nora-Athina Viniou; Ekaterini Stefanoudaki; Christina Hadjiaggelidou; Dimitrios Christoulas; Evgenia Verrou; Vassiliki Gastari; Sofia Papadaki; Genovefa Polychronidou; Athina Papadopoulou; Evlambia Giannopoulou; Efstathios Kastritis; Alexandra Kouraklis; Pavlina Konstantinidou; Achilles Anagnostopoulos; Konstantinos Zervas; Meletios A Dimopoulos
Journal:  Am J Hematol       Date:  2014-05-12       Impact factor: 10.047

3.  Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis.

Authors:  Quentin A Hill; Andy C Rawstron; Ruth M de Tute; Roger G Owen
Journal:  Blood       Date:  2014-06-17       Impact factor: 22.113

Review 4.  Solitary plasmacytoma of bone and asymptomatic multiple myeloma.

Authors:  M A Dimopoulos; L A Moulopoulos; A Maniatis; R Alexanian
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

5.  Impact of initial FDG-PET/CT and serum-free light chain on transformation of conventionally defined solitary plasmacytoma to multiple myeloma.

Authors:  Guillemette Fouquet; Stéphanie Guidez; Charles Herbaux; Zoé Van de Wyngaert; Sarah Bonnet; David Beauvais; Hélène Demarquette; Salim Adib; Bénédicte Hivert; Mathieu Wemeau; Céline Berthon; Louis Terriou; Valérie Coiteux; Margaret Macro; Olivier Decaux; Thierry Facon; Damien Huglo; Xavier Leleu
Journal:  Clin Cancer Res       Date:  2014-04-08       Impact factor: 12.531

6.  Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy.

Authors:  Valerie Reed; Jatin Shah; L Jeffery Medeiros; Chul S Ha; Ali Mazloom; Donna M Weber; Isidora Y Arzu; Robert Z Orlowski; Sheeba K Thomas; Ferial Shihadeh; Raymond Alexanian; Bouthaina S Dabaja
Journal:  Cancer       Date:  2011-03-22       Impact factor: 6.860

7.  Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients.

Authors:  Mahmut Ozsahin; Richard W Tsang; Philip Poortmans; Yazid Belkacémi; Michel Bolla; Fazilet Oner Dinçbas; Christine Landmann; Bernard Castelain; Jeroen Buijsen; Jürgen Curschmann; Sidney P Kadish; Anna Kowalczyk; Yavuz Anacak; Josef Hammer; Tan D Nguyen; Gabriela Studer; Rachel Cooper; Meriç Sengöz; Luciano Scandolaro; Abderrahim Zouhair
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-17       Impact factor: 7.038

Review 8.  International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.

Authors:  M Dimopoulos; E Terpos; R L Comenzo; P Tosi; M Beksac; O Sezer; D Siegel; H Lokhorst; S Kumar; S V Rajkumar; R Niesvizky; L A Moulopoulos; B G M Durie
Journal:  Leukemia       Date:  2009-05-07       Impact factor: 11.528

9.  Magnetic resonance imaging in the staging of solitary plasmacytoma of bone.

Authors:  L A Moulopoulos; M A Dimopoulos; D Weber; L Fuller; H I Libshitz; R Alexanian
Journal:  J Clin Oncol       Date:  1993-07       Impact factor: 44.544

10.  Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma.

Authors:  Bruno Paiva; Mauricio Chandia; Maria-Belen Vidriales; Enrique Colado; Teresa Caballero-Velázquez; Fernando Escalante; Alfonso Garcia de Coca; Maria-Carmen Montes; Ramon Garcia-Sanz; Enrique M Ocio; Maria-Victoria Mateos; Jesus F San Miguel
Journal:  Blood       Date:  2014-05-29       Impact factor: 22.113
  10 in total
  4 in total

Review 1.  Solitary Plasmacytoma.

Authors:  Sara Grammatico; Emilia Scalzulli; Maria Teresa Petrucci
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-08-23       Impact factor: 2.576

Review 2.  Current applications of multiparameter flow cytometry in plasma cell disorders.

Authors:  T Jelinek; R Bezdekova; M Zatopkova; L Burgos; M Simicek; T Sevcikova; B Paiva; R Hajek
Journal:  Blood Cancer J       Date:  2017-10-20       Impact factor: 11.037

3.  Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC).

Authors:  L Sanoja-Flores; J Flores-Montero; J J Garcés; B Paiva; N Puig; A García-Mateo; O García-Sánchez; A Corral-Mateos; L Burgos; E Blanco; J Hernández-Martín; R Pontes; M Díez-Campelo; P Millacoy; P Rodríguez-Otero; F Prosper; J Merino; M B Vidriales; R García-Sanz; A Romero; L Palomera; R Ríos-Tamayo; M Pérez-Andrés; J F Blanco; M González; J J M van Dongen; B Durie; M V Mateos; J San-Miguel; A Orfao
Journal:  Blood Cancer J       Date:  2018-11-19       Impact factor: 11.037

4.  Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era.

Authors:  F A Sharpley; P Neffa; F Panitsas; J Kothari; M Subesinghe; D Cutter; R Shcolnik Szor; G Aparedcida Martinez; V Rocha; K Ramasamy
Journal:  PLoS One       Date:  2019-07-23       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.